E. Ahlke

781 total citations
12 papers, 601 citations indexed

About

E. Ahlke is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, E. Ahlke has authored 12 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in E. Ahlke's work include Acute Lymphoblastic Leukemia research (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). E. Ahlke is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). E. Ahlke collaborates with scholars based in Germany, Austria and United States. E. Ahlke's co-authors include Ulrike Nowak‐Göttl, Joachim Boos, G. Werber, P. Schulze-Westhoff, J. Ritter, H. Jürgens, Gudrun Fleischhack, E. J. Verspohl, Gudrun Würthwein and Christiane Schumann and has published in prestigious journals such as Blood, European Journal of Cancer and Journal of Antimicrobial Chemotherapy.

In The Last Decade

E. Ahlke

12 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Ahlke Germany 12 424 295 169 96 79 12 601
Sofie Haglund Sweden 9 191 0.5× 60 0.2× 23 0.1× 47 0.5× 67 0.8× 17 342
Margien L. Seinen Netherlands 15 421 1.0× 58 0.2× 69 0.4× 33 0.3× 59 0.7× 23 674
Andreas Beilken Germany 12 60 0.1× 45 0.2× 81 0.5× 15 0.2× 55 0.7× 21 454
Marie Balsat France 11 121 0.3× 46 0.2× 171 1.0× 13 0.1× 34 0.4× 41 332
El-Monsor Shobowale–Bakre United Kingdom 7 340 0.8× 121 0.4× 63 0.4× 86 0.9× 63 0.8× 10 444
Y Touze France 2 325 0.8× 84 0.3× 81 0.5× 66 0.7× 31 0.4× 2 464
Pascale Catala France 1 321 0.8× 84 0.3× 81 0.5× 66 0.7× 31 0.4× 2 449
Peer de Graaf Netherlands 10 293 0.7× 60 0.2× 89 0.5× 27 0.3× 30 0.4× 13 496
Ulrik Malthe Overgaard Denmark 9 104 0.2× 51 0.2× 133 0.8× 12 0.1× 53 0.7× 33 309
Renate Blütters‐Sawatzki Germany 6 71 0.2× 55 0.2× 42 0.2× 71 0.7× 33 0.4× 12 268

Countries citing papers authored by E. Ahlke

Since Specialization
Citations

This map shows the geographic impact of E. Ahlke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ahlke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ahlke more than expected).

Fields of papers citing papers by E. Ahlke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ahlke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ahlke. The network helps show where E. Ahlke may publish in the future.

Co-authorship network of co-authors of E. Ahlke

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ahlke. A scholar is included among the top collaborators of E. Ahlke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ahlke. E. Ahlke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Nowak‐Göttl, Ulrike, E. Ahlke, Gudrun Fleischhack, et al.. (2003). Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood. 101(7). 2529–2533. 109 indexed citations
4.
Müller, Hans‐Joachim, Rita Beier, Claudia Lanvers, et al.. (2001). PEG-asparaginase (Oncaspar) 2500 U/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemotherapy and Pharmacology. 49(2). 149–154. 28 indexed citations
5.
Pinheiro, João Paulo Vieira, E. Ahlke, Ulrike Nowak‐Göttl, et al.. (1999). Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL‐BFM treatment protocols. British Journal of Haematology. 104(2). 313–320. 54 indexed citations
6.
Nowak‐Göttl, Ulrike, et al.. (1997). Changes in coagulation and fibrinolysis in childhood acute lymphoblastic leukaemia re-induction therapy using three different asparaginase preparations. European Journal of Pediatrics. 156(11). 848–850. 14 indexed citations
7.
8.
Nowak‐Göttl, Ulrike, E. Ahlke, P. Schulze-Westhoff, & Joachim Boos. (1996). Changes in coagulation and fibrinolysis in childhood ALL: a two‐step dose reduction of one E. coli asparaginase preparation. British Journal of Haematology. 95(1). 123–126. 26 indexed citations
9.
Boos, Joachim, G. Werber, E. Ahlke, et al.. (1996). Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. European Journal of Cancer. 32(9). 1544–1550. 172 indexed citations
10.
Nowak‐Göttl, Ulrike, et al.. (1996). Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL.. PubMed. 81(2). 127–31. 21 indexed citations
11.
Nowak‐Göttl, Ulrike, Joachim Boos, Johannes Wolff, et al.. (1995). Asparaginase decreases clotting factors in vitro: a possible pitfall?. International Journal of Clinical & Laboratory Research. 25(3). 146–148. 13 indexed citations
12.
Nowak‐Göttl, Ulrike, Joachim Boos, Johannes Wolff, et al.. (1994). Influence of two different e.coli asparaginase preparations on coagulation and fibrinolysis: A randomized trial. Fibrinolysis and Proteolysis. 8. 66–68. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofie Haglund Breakdown of academic impact, for papers by Margien L. Seinen Breakdown of academic impact, for papers by Andreas Beilken Breakdown of academic impact, for papers by Marie Balsat Breakdown of academic impact, for papers by El-Monsor Shobowale–Bakre Breakdown of academic impact, for papers by Y Touze Breakdown of academic impact, for papers by Pascale Catala Breakdown of academic impact, for papers by Peer de Graaf Breakdown of academic impact, for papers by Ulrik Malthe Overgaard Breakdown of academic impact, for papers by Renate Blütters‐Sawatzki
Rankless by CCL
2026